Lessons from Orchid Pharma’s story
The task force on APIs is too late to rescue Orchid Pharma but will hopefully prevent more API makers from burning out.
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Editor’s note
Mozambique tightens pharma export process
From March 15, Mozambique mandated pre shipment testing of pharma exports, choosing to start with India, which is its largest…
Yet another go at FDCs?
We seem to be slowly but surely moving towards the Centre’s goal of substituting branded medicines with generics
Going beyond cosmetic changes
The 40 odd transfers of drug inspectors/ technical officers that followed Dr Eswara Reddy's appointment as DCG(I) have not…
A spring cleaning at the CDSCO?
February saw a fairly massive churn in India's drug regulatory infrastructure
India Pharma Inc’s place in Modicare
Pharma companies will have to come up with strategies to play a meaningful role in the NHPS
Countering India Pharma Inc’ Achilles heel
India’s drug regulator, the Drug Controller General India (DCGI), should be cheered by a recent report from India Ratings and…
Sabke Saath, Pharma ka bhi Vikas?
All eyes are now on Finance Minister Arun Jaitley as he readies to present the Union Budget 2018-19, most probably on February 1
It’s Centre vs states, once again
AIDCOC says the proposed joint inspections of pharma manufacturing facilities by drug inspectors of the state and centre will lead…
Will 2018 be the turning point?
Besides analysing the past, we need to plan for the future
Time for a new strategy?
According to a recently released CII report, “Indian Roots, American Soil,” the life sciences, pharmaceuticals, and healthcare…
Who’s next, after Torrent-Unichem?
After a search that reportedly lasted a decade, Unichem Laboratories finally settled on Torrent Pharma as the best choice to sell…
Converting growth potential into a reality
This year's CPhI Annual Report released a ranking of countries as pharmaceutical destinations on various parameters
Balancing volumes with value
When the going gets tough, the tough get going. This adage could well describe the beleaguered pharma exporters of India
What ails India’s pharma exports?
It is no secret that declining pharmaceuticals exports have been worrying not just pharma honchos but the Prime Minister’s Office…
A double whammy for the sector?
As expected, the August 30 meeting called by the Department of Pharmaceuticals (DoP) to discuss the Draft Pharmaceutical Policy…
Draft pharma policy: Old wine in a new bottle?
The Draft Pharma Policy 2017 which was released for comments in mid-August, has an ambitious intent: to make drug pricing 'more…
Surviving serialisation
It was way back in 1963 that the US FDA finalised the first version of Good Manufacturing Practices (GMPs) for finished…
India Pharma Inc’s tryst with destiny continues
As we mark our 71st Independence Day this August 15, how far have we progressed on the medicines security front?
A wake up call for serialisation laggards
Pharma companies exporting to the US market who had their eye on the November 2017 deadline to comply with the US Drug Supply…